ArticleScientific reports2026
Effect of graphene nanoplatelets on the behaviour of cementitious compounds: an experimental investigation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Concrete has an inherent tendency towards brittle behaviour and micro-cracking, which can further degrade the durability in harsh environments. Graphene nanoplatelets (GNPs) have been recognized as highly potential nano-enhancements for improving the mechanical and durability performance of cement-based materials. While there is extensive literature evaluating the impact of GNPs on concrete, it is generally limited to low amounts of graphene, one or two properties assessed, and therefore, the overall impact of varying amounts of GNPs on the material remains unclear. The purpose of this research was to provide a thorough experimental assessment of how GNPs affect the fresh-state, mechanical and long-term durability properties of the concrete. Twenty-five different concretes at five strength levels (M20–M40) were made using GNPs at concentrations ranging from 0 to 20% by weight of cement. The experimental portion of this project included evaluations of fresh-state properties (workability and setting characteristics), mechanical properties (compressive strength, flexural strength, split tensile strength), and durability properties (water absorption, sulfate resistance, and rapid chloride ion permeation). The results show that incorporating GNP into cementitious composite systems significantly enhance their properties and performance. The compressive strength of the GNP containing systems reached around 47Mpa while the flexural strength of the same systems reached 7.3 Mpa. The split tensile strength of these systems showed significant improvement in comparison to control systems. Additionally, the durability of the systems was significantly enhanced with respect to water absorption (reduced from around 4.5 to 1.6%), sulphate expansion (from 12.5% to 3.8%) and chloride permeability (reduced to approximately 650 coulombs) all demonstrating substantial pore refinement and resistance to aggressive ions. The above improvements have been attributed to the nano-filling effect of GNP; nucleation of hydrates during curing; and crack bridging effects caused by the presence of GNP. The collective effects of GNP provide microstructural density through the formation of a well bonded matrix and improved interface. The highest strength and durability were achieved with 20% GNP, however a GNP dosage range of 5–10% GNP was determined to be the optimal balance of performance and workability. These data demonstrate the strong potential of GNP as a means to develop high performance and durable nano engineered concrete systems for the development of advanced structural and infrastructures systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.